Target intelligence / Profile preview

Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3)

Target
SLC20A1P3
Molecular classification
Other, Pseudogene
01

Overview

Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3) is a human pseudogene related in sequence to the solute carrier family 20 phosphate transporter (SLC20A1), but it does not encode a functional protein and is generally considered non-functional in terms of protein-coding capacity[1][3][7][9]. Pseudogenes such as SLC20A1P3 arise via gene duplication or retrotransposition events but accumulate disabling mutations such as premature stop codons or frameshifts, which prevent them from producing a functional protein product[9]. Although pseudogenes can sometimes act as regulators by producing non-coding RNAs that impact the expression of other genes, there is currently no evidence that SLC20A1P3 has such a regulatory, pathological, or therapeutic role[4][7]. Consequently, it is not considered a therapeutic target, nor are there known interacting drugs, mechanisms of action, or safety concerns[3][7]. There are no known roles for SLC20A1P3 in disease, drug action, or biomarker use[3][7]. No structured gene ontology functions or pathway data are available for this gene[7]. Conclusion: SLC20A1P3 is a pseudogene, not a functional target or druggable protein, and lacks evidence for use in therapeutics, biomarker development, or disease association. The inclusion of "pseudogene" and lack of functional annotation mean it is not considered a proper molecular target for therapeutics[3][7][9].

Other names
SLC20A1P3solute carrier family 20 (phosphate transporter) member 1 pseudogene 3
02

Mechanism of action

None

03

Biological functions

None documented for SLC20A1P3 itself; in general, pseudogenes can sometimes have regulatory roles, but no such evidence is reported for this gene[4][9].
04

Disease associations

None established for SLC20A1P3; no disease associations are reported[7].

Beyond the preview

Go deeper on Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 20 member 1 pseudogene 3 (SLC20A1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call